Expressions of hippocampal mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) in the single-prolonged stress-rats.
Post-traumatic stress disorder (PTSD) is a stress-related mental disorder caused by traumatic experience. Single-prolonged stress (SPS) is one of the animal models proposed for PTSD. Rats exposed to SPS showed enhanced inhibition of the hypothalamo-pituitary-adrenal (HPA) axis, which has been reliably reproduced in patients with PTSD. Mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) in the hippocampus regulate HPA axis by glucocorticoid negative feedback. Abnormalities in negative feedback are found in PTSD, suggesting that GR and MR might be involved in the pathophysiology of these disorders.In the present study, we performed immunohistochemistry and western blotting to examine the changes in hippocampal MR- and GR-expression after SPS. Immunohistochemistry revealed decreased MR- and GR-immunoreactivity (ir) in the CA1 of hippocampus in SPS animals. Change in GR sub-distribution was also observed, where GR-ir was shifted from nucleus to cytoplasm in SPS rats. Western blotting showed that SPS induced significantly decreased MR- and GR-protein in the whole hippocampus, although the degree of decreased expression of both receptors was different. Meanwhile, we also found the MR/GR ratio decreased in SPS rats. In general, SPS induced down-regulation of MR- and GR-expression. These findings suggest that MR and GR play critical roles in affecting hippocampal function. Changes in MR/GR ratio may be relevant for behavioral syndrome in PTSD.
Zhe
Du
D
Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, China.
Fang
Han
H
Yuxiu
Shi
S
Eur J Neurosci. 1994 Jul 1;6(7):1072-9
7952288
Pharmacol Biochem Behav. 1996 May;54(1):261-7
8728567
Acta Neuropsychiatr. 2003 Dec;15(6):354-67
26983771
J Neural Transm (Vienna). 1998;105(8-9):987-1004
9869331
Psychoneuroendocrinology. 1995;20(4):385-94
8532822
J Neuroendocrinol. 1999 Jan;11(1):11-7
9918224
J Biol Chem. 2001 Apr 27;276(17):14299-307
11278286
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12480-4
8618925
J Steroid Biochem Mol Biol. 1993 Dec;47(1-6):183-90
8274434
Physiol Behav. 1992 Nov;52(5):945-51
1484851
Am J Psychiatry. 2004 Dec;161(12):2194-200
15569889
Crit Care Med. 2003 Jul;31(7):1971-80
12847391
Arch Gen Psychiatry. 1994 Sep;51(9):701-7
8080346
Brain Res Dev Brain Res. 1991 Jul 16;61(1):33-43
1655309
Neuroendocrinology. 1997 Mar;65(3):189-99
9088000
Psychoneuroendocrinology. 2000 Jan;25(1):1-35
10633533
Endocr Rev. 1998 Jun;19(3):269-301
9626555
J Chem Neuroanat. 2006 Apr;31(3):216-25
16533592
Biol Psychiatry. 1991 Nov 15;30(10):1031-48
1661614
Biol Psychiatry. 2001 Mar 1;49(5):391-404
11274650
Psychoneuroendocrinology. 1995;20(6):655-75
8584606
Cell Mol Neurobiol. 1993 Aug;13(4):433-55
8252612
Mol Endocrinol. 1989 Nov;3(11):1886-94
2558306
Brain Res. 1997 Dec 19;778(2):293-301
9459546
Brain Res Mol Brain Res. 1998 Apr;55(2):198-208
9582422
Neurosci Res. 2005 Apr;51(4):371-81
15740800
Psychopharmacology (Berl). 2006 Dec;189(2):165-73
17031709
Brain Res. 1991 Jul 19;554(1-2):312-5
1933312
Neurobiol Aging. 2003 May-Jun;24 Suppl 1:S69-76; discussion S81-2
12829112